1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yl nitrate

ID: ALA3763669

PubChem CID: 9837337

Max Phase: Preclinical

Molecular Formula: C9H18N2O4

Molecular Weight: 218.25

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1(C)CC(O[N+](=O)[O-])CC(C)(C)N1O

Standard InChI:  InChI=1S/C9H18N2O4/c1-8(2)5-7(15-11(13)14)6-9(3,4)10(8)12/h7,12H,5-6H2,1-4H3

Standard InChI Key:  DHHTZVHCRMTEHV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 15 15  0  0  0  0  0  0  0  0999 V2000
    1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990    0.7500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3383    1.3500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3238   -0.1256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2708   -1.9497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0531    2.0753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0530    2.0754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5973   -1.5031    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5951   -3.0039    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6331   -3.6060    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5548   -3.6021    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  0
  5  8  1  0
  5  9  1  0
  3 10  1  0
  3 11  1  0
  1 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
M  CHG  2  13   1  15  -1
M  END

Alternative Forms

Associated Targets(non-human)

Rhesus monkey (3147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 218.25Molecular Weight (Monoisotopic): 218.1267AlogP: 1.61#Rotatable Bonds: 2
Polar Surface Area: 75.84Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.64CX LogP: 0.84CX LogD: 0.84
Aromatic Rings: Heavy Atoms: 15QED Weighted: 0.56Np Likeness Score: -0.07

References

1. Acharya S, Rogers P, Krishnamoorthy RR, Stankowska DL, Dias HV, Yorio T..  (2016)  Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy.,  26  (5): [PMID:26832784] [10.1016/j.bmcl.2015.12.030]

Source